Joana Jerónimo

University of Lisbon

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Diogo Telles‐Correia

University of Lisbon

Duarte Janela

University Hospital of Geneva

Tânia Muñoz Hornos

Carla Ferreira

University of Lisbon

João Rema

University of Lisbon

Daniel Sampaio

Universidade Federal de Pernambuco

Tânia Forster–Carneiro

Universidade Estadual de Campinas (UNICAMP)

Elie Cheniaux

Universidade Federal do Rio de Janeiro

Ana Luı́sa Santos

University of Coimbra

Pedro Câmara Pestana

University of Lisbon

Cooperative Institutions

University of Lisbon

Hospital de Santa Maria

Centro Hospitalar Lisboa Norte

Administração Regional de Saúde de Lisboa e Vale do Tejo

Universidade Federal do Rio de Janeiro

Instituto Politécnico de Lisboa

University Hospital of Geneva

Instituto de Medicina Tropical

Hospital da Senhora da Oliveira Guimarães

Hospital Braga

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Anorexia Nervosa and Bone Metabolism: An Extreme Case

Joana Jerónimo

Anorexia nervosa

Anorexia

Bone remodeling

10.26226/morressier.5a6ef3edd462b80290b581bb

Cite

Citations (0)

Anorexia Nervosa and Bone Metabolism

Joana Jerónimo

Anorexia nervosa

Anorexia

Bone remodeling

10.26226/morressier.5a6ef3edd462b80290b5818a

Cite

Citations (0)

Eating disorders in children and adolescents: what is the difference?

Joana Jerónimo

10.26226/morressier.59d4913ad462b8029238a31f

Cite

Citations (0)

Psychostimulant Augmentation of Antidepressant Therapy in Depression: a Systematic Review and Meta-Analysis

Current Treatment Options in Psychiatry (2023)

Duarte Janela Joana Jerónimo João Rema Diogo Telles‐Correia Filipa Novais

Abstract Purpose of Review To evaluate the effectiveness of psychostimulant augmentation of antidepressants in the treatment of depression in adults. Recent Findings In our analysis of 13 RCTs involving 2478 participants, psychostimulant augmentation demonstrated a statistically significant reduction in depressive symptom severity compared to placebo augmentation ( N = 1827; SMD = − 0.18; 95% CI (− 0.36, − 0.01); p = 0.04, I 2 = 65%). However, we did not observe a significant increase in remission rates ( N = 1709; OR = 1.30; 95% CI (0.97, 1.75); p = 0.08, I 2 = 32%). Summary Depression, a pressing global health issue, is typically treated with antidepressant monotherapy, offering limited relief. Our study introduces a potential breakthrough: psychostimulant augmentation of antidepressants, which significantly alleviates depressive symptoms. Nevertheless, larger high-quality trials evaluating a wider range of drugs are necessary to further explore and strengthen our findings.

Depression

10.1007/s40501-023-00307-4

Cite

Citations (0)

Espaço S - Um modelo de intervenção em alunos de Medicina

Congresso Internacional de Psicologia da Criança e do Adolescente (2016)

Filipa Cardoso de Menezes Joana Jerónimo Tânia Forster–Carneiro Tânia Muñoz Hornos Abel Matos Santos

Source

Cite

Citations (0)

Patients with Eating Disorders: Outcome Inpatient Care

Joana Jerónimo

Inpatient care

10.26226/morressier.5a6ef3edd462b80290b581b6

Cite

Citations (0)

Suicide Attempt in a Patient with Sibutramine Associated Psychosis

Acta Médica Portuguesa (2021)

Pedro Câmara Pestana Carla Ferreira Ana Luı́sa Santos Joana Jerónimo Licínia Ganança

Sibutramine is a serotonin-norepinephrine-dopamine reuptake inhibitor, initially developed as a potential antidepressant and later approved for the management of obesity. Sibutramine use is also associated with psychiatric symptoms, namely mania, panic attacks, and, less frequently, psychosis. We report the case of a 32-year-old man, admitted to our hospital due to a suicide attempt in the context of sibutramine-associated psychosis. The symptoms remitted completely after discontinuation of sibutramine and a brief period of antipsychotic medication. The aim of this manuscript is to highlight the importance of the recognition of sibutramine-associated psychosis, to discuss the possible pathophysiology and the proper clinical and therapeutic management.

Sibutramine

Discontinuation

10.20344/amp.14304

Cite

Citations (2)

Anorexia Nervosa in Child and Adolescents

Joana Jerónimo

Anorexia nervosa

Anorexia

10.26226/morressier.5a6ef3edd462b80290b58185

Cite

Citations (0)

Formal Thought Disorders–Historical Roots

Frontiers in Psychiatry (2018)

Joana Jerónimo Tiago Pinto Queirós Elie Cheniaux Diogo Telles‐Correia

In this article the authors intend to review in an intelligible and comprehensive way the historical roots of Formal Thought Disorders. Early descriptions of thought disorders date back to the XIX century with Esquirol, but it was in the first half of the XX century that several authors introduced the main features of the actual concept of Formal Thought Disorders. Emil Kraepelin described akataphasia (inability to find the appropriate expression for a thought) in patients with dementia praecox (a term that some years later was replaced by schizophrenia). Bleuler and Kretschmer also identified in schizophrenic patients a generalized "loosening of associations" and Carl Schneider described several Formal Thought Disorders such as derailment, fusion, omission, suspension and driveling. At the end of the XX century Nancy Andreasen studied the classical descriptions regarding Formal Thought Disorders, reclassified them and also introduced a scale to assess them. Although the specificity of these symptoms in schizophrenia and psychosis has been a source of controversy among the different authors, the importance given to their presence in these mental disorders is universal. We defend that it is crucial that these historical and conceptual elements are grasped in order to assess Formal Thought Disorders for clinical and research purposes.

Dementia praecox

Thought disorder

Derailment

10.3389/fpsyt.2018.00572

Cite

Citations (20)